Back to results
US 2026/0076956 A1Published application
Methods for regressing or reversing fibrosis and/or liver cirrhosis in a subject in need thereof using high-dose niacin, or a niacin analog thereof
OwnerMoti Lal Kashyap, Vaijinath Kamanna +1inventors
InventorsMoti Lal Kashyap, Vaijinath Kamanna, Shobha Kamanna
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods to reverse or regress fibrosis and/or liver cirrhosis in a subject in need thereof, using high-dose (pharmacologic) niacin, or a niacin analog thereof.
Claims20
A method to reverse or regress fibrosis and/or liver cirrhosis in a subject in need thereof, comprising:
- administering to a subject having fibrosis and/or liver cirrhosis one or more pharmaceutical doses of a pharmaceutical composition comprising niacin, or of a niacin analog thereof, wherein the pharmaceutical composition comprises 250 mg to 2000 mg of niacin, or niacin equivalent dosing of a niacin analog thereof,
- wherein the subject is administered a total daily dose of 250 mg to 6000 mg of niacin, or niacin equivalent dosing of a niacin analog thereof, and
- wherein administration of the one or more pharmaceutical doses of niacin or a niacin analog thereof reverses or regresses fibrosis and/or liver cirrhosis in the subject.
Dependencies are inferred from the claim text.